FDA Inspection 876913 — Cayman Pharma s.r.o.

Cayman Pharma s.r.o. — FEI 3003625059

The FDA completed an inspection of Cayman Pharma s.r.o. on March 27, 2014 in Neratovice. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 27, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Neratovice (Czech Republic)